Webinar :Register now for webinar on 'Trade BankNifty in just 15 minutes a day' - By Asmita Patel

eye-on-india

3-Point Analysis | Gland Pharma IPO: Strong play on global generic injectables; should investors subscribe?

Gland Pharma IPO comes at a time when global pharma industry is in a sweet spot. Should you subscribe? Let’s find out in this edition of 3-Point Analysis.

LATEST VIDEOS

Watch More →

A collection of the most-viewed Moneycontrol videos.

3 Point Analysis

Watch More →

A breakdown of news from business, economy and policy

Watch and Follow our leading shows

Sections